South America Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product and Type (Prescription Drugs and OTC Drugs)

List of Tables

The SAM dry eye products market is expected to grow from US$ 248.58 million in 2021 to US$ 315.29 million by 2028. It is estimated to grow at a CAGR of 3.5% from 2021 to 2028.

Development of Technologies Based on Stem Cell Therapy

The technologies are emerging based on stem cell therapy that can help in treating a dry eye condition. The aim is to prevent disease development, regenerate, and maintain corneal transparency. Most of the recent advances do not respond to conventional methods. Therefore, researchers prefer autologous or allogeneic serum drops, platelet-derived plasma products, and umbilical cord blood serum to study them as a treatment method. Additionally, the researchers are focusing on using cytokines and different cell sources, such as mesenchymal stem cells, more preferably to cure dry eye conditions. During the studies, it was found that mesenchymal cells assist in improving tear volume, tear-film stability, epithelial recovery, and the number of goblet cells. The cells help decrease the number of meibomian gland injuries in the conjunctiva, which is expected to be the most promising advancement for trying eye condition treatment. The other stem cell therapy-based treatment is by using lubricin. Lubricin is a protein in the tear film that allows lubrication between the eye surface and the eyelid. The researchers are aiming to introduce a proper treatment that can cure dry eye conditions completely. Thus, advancements in the healthcare industry that have allowed the integration of biotechnology and pharmaceutical are likely to propel the market growth during the forecast period.

Market Overview

The SAM dry eye products market includes the consolidated markets for Brazil, Argentina, and the Rest of SAM. Brazil held the largest share of the SAM dry eye products market in 2021. Brazil is the largest country in SAM, with the largest population. It offers several growth opportunities as various conferences are being held in the country for ophthalmology-the conference assists in exploring different technologies in the medical field. In addition, the country is facing the problem of an aging population, which is expected to increase the demand for dry eye products. In addition, the growing medical tourism in the country is likely to influence the market growth during the forecast period. Also, there have been various studies conducted to understand the causes of dry eye conditions. For instance, the article "Clinical indicators of dry eye severity nursing outcome in intensive care unit," published in October 2019, states that clinical characteristics of patients in the intensive care unit hinder the damage of eye health and causes the severity of dry eye. Thus, the factors mentioned above are expected to provide growth opportunities to the market during the forecast period.

SAM Dry Eye Products Market Revenue and Forecast to 2028 (US$ Million)

SAM Dry Eye Products Market Segmentation

The SAM dry eye products market is segmented based on product, type, and country.

Based on product, the SAM dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held the largest market share in 2021. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.

Based on type, the SAM dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held a larger market share in 2021.

Based on country, the SAM dry eye products market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2021.

AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH are among the leading companies operating in the SAM dry eye products market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM dry eye products market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the dry eye products market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPRE00028877

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Dry Eye Products Market - By Product
- 1.3.2 SAM Dry Eye Products Market - By Type
- 1.3.3 SAM Dry Eye Products Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Dry Eye Products Market - Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion

5. SAM Dry Eye Products Market - Key Market Dynamics

5.1 Market Driver
- 5.1.1 Rising Incidences of Dry Eye
- 5.1.2 Growing Older Population
5.2 Market Restraints
- 5.2.1 Side Effects Caused Due to Eye Drops
5.3 Market Opportunities
- 5.3.1 Stem Cell Therapy
5.4 Future Trends
- 5.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
5.5 Impact Analysis of Drivers and Restraints

6. Dry Eye Products Market - SAM Analysis

6.1 SAM Dry Eye Products Market Revenue Forecast and Analysis

7. SAM Dry Eye Products Market Analysis - By Product

7.1 Overview
7.2 SAM Dry Eye Products Market Revenue Share, by Product (2021 and 2028)
7.3 Artificial Tears
- 7.3.1 Overview
- 7.3.2 Artificial Tears: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Over-The-Counter (OTC) Artificial Tears
  - 7.3.3.1 Overview
  - 7.3.3.2 OTC Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Prescription Artificial Tears
  - 7.3.4.1 Overview
  - 7.3.4.2 Prescription Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
7.4 Antibiotics Drops
- 7.4.1 Overview
- 7.4.2 Antibiotic Drops: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Hormone Drops
- 7.5.1 Overview
- 7.5.2 Hormone Drops: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)

8. SAM Dry Eye Products Market Analysis - By Type

8.1 Overview
8.2 SAM Dry Eye Products Market, by Type, 2021 and 2028 (%)
8.3 OTC Drugs
- 8.3.1 Overview
- 8.3.2 OTC Drugs: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Prescription Drugs
- 8.4.1 Overview
- 8.4.2 Prescription Drugs: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)

9. SAM Dry Eye Products Market - Country Analysis

9.1 Overview
- 9.1.1 SAM: Dry Eye Products Market, by Country, 2021 & 2028 (%)
- 9.1.2 Brazil: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.2.1 Overview
  - 9.1.2.2 Brazil: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.2.3 Brazil Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.2.3.1 Brazil: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.2.4 Brazil Dry Eye Products Market, by Type - Revenue and Forecast to 2028 (US$ Million)
- 9.1.3 Argentina: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.3.1 Overview
  - 9.1.3.2 Argentina: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.3.3 Argentina Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.3.3.1 Argentina: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.3.4 Argentina Dry Eye Products Market, by Type - Revenue and Forecast to 2028 (US$ Million)
- 9.1.4 Rest of SAM: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.4.1 Overview
  - 9.1.4.2 Rest of SAM: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.4.3 Rest of SAM Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.3.1 Rest of SAM: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.4.4 Rest of SAM Dry Eye Products Market, by Type - Revenue and Forecast to 2028 (US$ Million)

10. Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Novartis AG
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Santen Pharmaceutical Co., Ltd.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Johnson and Johnson Services, Inc.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 OASIS Medical
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 URSAPHARM Arzneimittel GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 ROHTO Pharmaceutical Co, Ltd.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 OCuSOFT Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Bausch Health Companies Inc.
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 AbbVie Inc.
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Prestige Consumer Healthcare Inc.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 Glossary of Terms